Haleon plc (NYSE:HLN) Sees Significant Increase in Short Interest

Haleon plc (NYSE:HLN) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 25,670,000 shares, a growth of 40.0% from the January 15th total of 18,340,000 shares. Based on an average trading volume of 8,640,000 shares, the days-to-cover ratio is presently 3.0 days. Approximately 0.6% of the company’s shares are short sold.

Analyst Ratings Changes

Several brokerages have issued reports on HLN. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Haleon presently has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Down 2.5 %

Shares of HLN stock traded down $0.25 on Friday, hitting $9.71. 5,836,820 shares of the stock were exchanged, compared to its average volume of 12,350,782. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $43.93 billion, a P/E ratio of 28.54, a price-to-earnings-growth ratio of 2.70 and a beta of 0.28. The business has a 50-day moving average of $9.54 and a 200 day moving average of $9.80. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Procyon Advisors LLC boosted its position in shares of Haleon by 41.3% during the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after buying an additional 67,329 shares during the period. HighTower Advisors LLC boosted its position in Haleon by 27.2% during the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after purchasing an additional 74,970 shares during the last quarter. Jane Street Group LLC boosted its position in Haleon by 1,689.4% during the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after purchasing an additional 250,169 shares during the last quarter. Chartwell Investment Partners LLC boosted its position in Haleon by 107.8% during the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after purchasing an additional 246,594 shares during the last quarter. Finally, Townsquare Capital LLC boosted its position in Haleon by 29.8% during the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after purchasing an additional 109,217 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.